Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian Study

This nationwide study underscores the variability in HS presentation and management across Italy. Liver biopsy remains essential for diagnosis and staging. While steroids are the primary treatment, many patients require second-line therapies. Our finding of a higher BMI in patients with CSPH suggests that metabolic factors may play a role in disease progression, warranting further investigation.

Authors

Institutions

Publication Details

Journal
Liver International
Published
2025-12-01
DOI
https://doi.org/10.1111/liv.70459
Citations
1
Primary Topic
Sarcoidosis and Beryllium Toxicity Research
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian Study

Federica Malinverno, Maria Cristina Morelli, Lorenzo Surace, Adele Rocchetti et al.
1 citations
Liver International
Sarcoidosis and Beryllium Toxicity Research
1.16
article

Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian Study

Federica Malinverno, Maria Cristina Morelli, Lorenzo Surace, Adele Rocchetti, Edoardo G. Giannini, Francesca Terracciani, Mauro Viganò, Marco Carbone, R. Reati, Rachele Rapetti, Gianluca Svegliati‐Baroni, Gianluca Ferrari, Michele Campigotto, Simone Saibeni, Umberto Vespasiani‐Gentilucci, Paola Torreri, Gianpiero Manes, Andréa Martini, Cristina Colarossi, Giovanni Perricone, C. Della Corte, Giulia Pieri, Emanuele Durante‐Mangoni, Daphne D’Amato, Alessio Aghemo, Pietro Invernizzi, Ilaria Arena, Germana de Nucci, Elisabetta Degasperi, Gabriele Missale, Marco Silano, Nicola Riccardo Pugliese, Alessandro Federico, Raffaella Gallo, Loredana Simone, E. Morana
article en
1 citations

Abstract

This nationwide study underscores the variability in HS presentation and management across Italy. Liver biopsy remains essential for diagnosis and staging. While steroids are the primary treatment, many patients require second-line therapies. Our finding of a higher BMI in patients with CSPH suggests that metabolic factors may play a role in disease progression, warranting further investigation.

Liver InternationalVol. 46(1)
Marche Polytechnic University (IT), Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), University of Parma (IT), Humanitas University (IT), University of Padua (IT), Università Campus Bio-Medico (IT), University of Campania "Luigi Vanvitelli" (IT), University of Ferrara (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Ospedale Maggiore (IT), Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT), AULSS 2 Marca Trevigiana (IT), Ospedale Papa Giovanni XXIII (IT), Azienda Ospedaliera San Gerardo (IT), Azienda USL di Bologna (IT), National Institute of Health (AM), University of Campania "Luigi Vanvitelli" (IT), General Hospital of Rhodes (GR), Accademia di Belle Arti di Catanzaro (IT), Ospedale Monaldi (IT), ERN GUARD-Heart (NL), Campus Bio Medico University Hospital (IT), Azienda Ospedale - Università Padova (IT), Carlo Forlanini Hospital (IT), IRCCS Humanitas Research Hospital (IT), Aziende Socio Sanitaria Territoriale Rhodense, University of Turin (IT), University of Milano-Bicocca (IT), University of Genoa (IT)
Openalex Percentile: Top 16%
Sarcoidosis and Beryllium Toxicity Research
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.